Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Inhibiting the expression of hepatocyte nuclear factor 4 alpha attenuates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.

Chen EQ, Gong DY, Leng XH, Bai L, Liu C, Wang LC, Tang H.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):624-9.

PMID:
23232634
2.

Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.

Kim SJ, Cho HI, Kim SJ, Park JH, Kim JS, Kim YH, Lee SK, Kwak JH, Lee SM.

Eur J Pharmacol. 2014 Sep 5;738:66-73. doi: 10.1016/j.ejphar.2014.05.024. Epub 2014 May 27.

PMID:
24877692
3.

Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.

Kang JW, Kim DW, Choi JS, Kim YS, Lee SM.

Food Chem Toxicol. 2013 Jul;57:132-9. doi: 10.1016/j.fct.2013.03.016. Epub 2013 Mar 25.

PMID:
23535186
4.

Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.

Ben Ari Z, Avlas O, Pappo O, Zilbermints V, Cheporko Y, Bachmetov L, Zemel R, Shainberg A, Sharon E, Grief F, Hochhauser E.

Cell Physiol Biochem. 2012;29(1-2):41-50. doi: 10.1159/000337585. Epub 2012 Mar 1.

5.

Intraperitoneal administration of fetuin-A attenuates D-galactosamine/lipopolysaccharide-induced liver failure in mouse.

Zhang P, Shen H, Huang J, Wang H, Zhang B, Zhou R, Zhong B, Fan X.

Dig Dis Sci. 2014 Aug;59(8):1789-97. doi: 10.1007/s10620-014-3071-0. Epub 2014 Mar 7.

6.

Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.

Yin X, Gong X, Jiang R, Zhang L, Wang B, Xu G, Wang C, Wan J.

J Gastroenterol Hepatol. 2014 Jun;29(6):1308-15. doi: 10.1111/jgh.12525.

PMID:
24476051
7.

Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.

Yang XF, He Y, Li HY, Liu X, Chen H, Liu JB, Ji WJ, Wang B, Chen LN.

Mol Med Rep. 2014 Jul;10(1):555-9. doi: 10.3892/mmr.2014.2164. Epub 2014 Apr 24.

PMID:
24788561
8.

An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.

Takamura M, Matsuda Y, Yamagiwa S, Tamura Y, Honda Y, Suzuki K, Ichida T, Aoyagi Y.

Life Sci. 2007 Mar 13;80(14):1335-44. Epub 2007 Jan 20.

PMID:
17300814
9.

Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice.

Ben-Ari Z, Zilbermints V, Pappo O, Avlas O, Sharon E, Greif F, Cheporko Y, Ravid A, Shapiro R, Hochhauser E.

Transplantation. 2011 Jul 15;92(1):18-24. doi: 10.1097/TP.0b013e31821cdea5.

PMID:
21516061
10.

Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.

Kitazawa T, Tsujimoto T, Kawaratani H, Fukui H.

J Gastroenterol Hepatol. 2010 May;25(5):1009-12. doi: 10.1111/j.1440-1746.2009.06145.x.

PMID:
20546456
11.

Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.

Liu H, Zhang W, Dong S, Song L, Zhao S, Wu C, Wang X, Liu F, Xie J, Wang J, Wang Y.

J Ethnopharmacol. 2015 Dec 24;176:69-78. doi: 10.1016/j.jep.2015.10.029. Epub 2015 Oct 19.

PMID:
26494508
12.

Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.

Furuya S, Kono H, Hara M, Hirayama K, Sun C, Fujii H.

J Surg Res. 2015 Dec;199(2):487-93. doi: 10.1016/j.jss.2015.05.060. Epub 2015 Jun 4.

13.

Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.

Jin Q, Jiang S, Wu YL, Bai T, Yang Y, Jin X, Lian LH, Nan JX.

Phytomedicine. 2014 Jan 15;21(2):141-7. doi: 10.1016/j.phymed.2013.07.016. Epub 2013 Sep 4.

PMID:
24011530
14.

Hepatoprotective effects of Sedum sarmentosum on D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure.

Lian LH, Jin X, Wu YL, Cai XF, Lee JJ, Nan JX.

J Pharmacol Sci. 2010;114(2):147-57. Epub 2010 Sep 11.

15.

[Tumor necrosis factor alpha and enterocyte apoptosis in mice with fulminant hepatic failure].

Song HL, Lü S, Liu P.

Zhonghua Gan Zang Bing Za Zhi. 2005 Apr;13(4):290-3. Chinese.

PMID:
15850520
16.

Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice.

Gong X, Luo FL, Zhang L, Li HZ, Wu MJ, Li XH, Wang B, Hu N, Wang CD, Yang JQ, Wan JY.

Int Immunopharmacol. 2010 Mar;10(3):357-63. doi: 10.1016/j.intimp.2009.12.010. Epub 2009 Dec 28.

PMID:
20036342
17.

Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.

Lee WC, Kim JK, Kang JW, Oh WY, Jung JY, Kim YS, Jung HA, Choi JS, Lee SM.

Food Chem Toxicol. 2010 Jan;48(1):222-8. doi: 10.1016/j.fct.2009.10.004. Epub 2009 Oct 8.

PMID:
19818826
18.

Cordyceps sinensis prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.

Cheng YJ, Cheng SM, Teng YH, Shyu WC, Chen HL, Lee SD.

Am J Chin Med. 2014;42(2):427-41. doi: 10.1142/S0192415X14500281.

PMID:
24707872
19.

Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.

Xia X, Su C, Fu J, Zhang P, Jiang X, Xu D, Hu L, Song E, Song Y.

Int Immunopharmacol. 2014 Oct;22(2):293-302. doi: 10.1016/j.intimp.2014.07.008. Epub 2014 Jul 18.

PMID:
25046589
20.

Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.

Gong X, Zhang L, Jiang R, Wang CD, Yin XR, Wan JY.

J Appl Toxicol. 2014 Mar;34(3):265-71. doi: 10.1002/jat.2876. Epub 2013 Apr 26.

PMID:
23620140

Supplemental Content

Support Center